Global Biochips Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

  • ID: 3454308
  • Report
  • Region: Global
  • 140 Pages
  • Occams Business Research and Consulting
1 of 4
Global Biochips Market Is Growing Approximately At a CAGR Of 18% From 2015-2021

FEATURED COMPANIES

  • Affymetrix inc
  • Bio-rad laboratories inc
  • Digital genomics inc
  • Gamida for life group
  • ISU ABXIS co ltd
  • Predictive biosciences
  • MORE
A Biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that can perform hundreds or thousands of simultaneous biochemical reactions in order to achieve higher throughput and speed. Biochips help researchers to quickly see large number of biological analytics and are used in a range of research applications within the biotechnology sector, including pharmaceuticals, proteomics and genomics. Biochips are also used in analysis of organic molecules associated with living organisms and help in identifying gene sequences, airborne toxins, environmental pollutants and other biochemical constituents. Although, biochips have been developed and commercialized in mid eighties but the market has transformed in the starting of last decade.

Presently, the biochips market is undergoing rapid expansion with the discovery of new applications and the development of existing technologies. The key driving forces for the market of biochips are: growth in personalized medicine market, increase in government spending/ private investment in healthcare budgets and R&D respectively, rising case of lifestyle related diseases and so on. Various factors such as less accuracy of biochips that may lead to wrong analysis, low rate of translation of discoveries in drugs, medical devices and protein biomarkers, low acceptance due to high cost and availability of alternative technologies are restraining the growth of biochips market.

The key players in global biochips market are Agilent technologies Affymetric Inc, Gene system Inc, Agendia BV Inc, Customarray inc, Digital genomics inc, Bio chain institute Inc, Biomerieux SA , Bio-rad laboratories inc, Cepheid Inc, Caliper life sciences Inc, Cybrdi Inc, EMD Millipore, Elim Biopharmaceuticals, Falcon Genomics, Genalyte and so on.

Companies profiled in this report
1 Agilent technologies
2 Affymetrix inc
3 Gene system inc
4 Agendia BV inc
5 Customarray inc
6 Digital genomics inc
7 Bio chain institute Inc
8 Biomerieux SA
9 Bio-rad laboratories inc
10 Cepheid Inc
11 Caliper life sciences inc
12 Cybrdi inc
13 EMD Millipore
14 Elim Biopharmaceuticals
15 Falcon Genomics
16 Genalyte
17 Oxford gene technology
18 Wafergen biosystems inc
19 Predictive biosciences
20 Fluidigm corp
21 Gamida for life group
22 Illumina Inc
23 Life technologies corp
24 Origene technologies Inc
25 Perkinelmer inc
26 Roche nimblegen inc
27 Sequenom
28 Sigma aldrich corp
29 Imgenex
30 ISU ABXIS co ltd
31 Quantalife inc

This Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. In-depth profiling of companies

Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Affymetrix inc
  • Bio-rad laboratories inc
  • Digital genomics inc
  • Gamida for life group
  • ISU ABXIS co ltd
  • Predictive biosciences
  • MORE
1. Introduction
1.1. Executive summary
1.2. Estimation methodology
2. Market overview
2.1. Market definition and scope
2.2. Key findings
2.3. Parametric analysis
2.3.1. Prevalence of life style oriented diseases
2.3.2. Incidence and prevalence rate of cancer
2.3.3. Adoption of biochips in major hospitals and clinics across geographies
2.3.4. Adoption of diagnostics through biochips in research centers
2.3.5. Growing healthcare expenditure across geographies
2.4. Key market insights
2.4.1. Top 3 emerging countries
2.4.2. Top 3 revenue generating segments
2.4.3. Top growing markets and emerging trends
2.4.4. R&D scenario in biochips market
2.4.4.1. Human genome project
2.4.4.2. Silicon technology for electronic biochip
2.5. Competitive intelligence
2.5.1. Market share analysis
2.5.2. Top winning strategies
2.5.3. Case studies: top competitive moves
2.6. Value chain analysis
2.7. Key buying criteria
2.8. Strategic recommendation
2.9. Strategic conclusions
3. Market determinants
3.1. Market drivers
3.1.1. Global growth in personalized medicines
3.1.2. Global increase in government and private funding
3.1.3. Increase in cancer diagnostics and treatment
3.1.4. Innovation giving rise to biochips market
3.1.5. Global increase in life style oriented disease and other new diseases
3.1.6. Technological advancement
3.1.7. Global increase in healthcare expenditure
3.1.8. Increase in r&d from major players
3.2. Market restraints
3.2.1. Less accuracy of biochips may lead to wrong analysis
3.2.2. Low rate of translation of discoveries in drugs, medical devices and protein biomarkers
3.3. Market challenges
3.3.1. High expertise required for the diagnosis through biochips
3.3.2. Creating awareness for increasing adoption of biochip market
3.4. Market opportunities
3.4.1. Innovative detection technology with economic reagents to come in near future
3.4.2. Untapped APAC region has huge scope for ophthalmology drug and device market
3.4.3. Increase in adoption of lab-on-chip technology
4. Sector Analysis
4.1. Parent market
4.2. Sub-segment market
4.3. Alternative market
5. Market Segmentation
5.1. Global biochips market by application
5.1.1. Global DNA micro array market by application, 2014-2021,($ millions)
5.1.1.1. Global gene expression market, 2014-2021,($ millions)
5.1.1.2. Global SNP genotyping market, 2014-2021,($ millions)
5.1.1.3. Global Cancer diagnosis and treatment market, 2014-2021,($ millions)
5.1.1.4. Global Genomics, 2014-2021,($ millions)
5.1.1.5. Global drug discovery market , 2014-2021,($ millions)
5.1.1.6. Global other DNA micro array market, 2014-2021,($ millions)
5.1.2. Global Lab on a chip market by application , 2014-2021,($ millions)
5.1.2.1. Global Genomics market s, 2014-2021,($ millions)
5.1.2.2. Global proteomics market, 2014-2021,($ millions)
5.1.2.3. Global drug discovery, 2014-2021 market,($ millions)
5.1.2.4. Global diagnostics market, 2014-2021,($ millions)
5.1.2.5. Global other lab on chip market, 2014-2021,($ millions)
5.1.3. Global protein microarray market by application , 2014-2021,($ millions)
5.1.3.1. Global expression profiling market , 2014-2021,($ millions)
5.1.3.2. Global proteomics market, 2014-2021,($ millions)
5.1.3.3. Global high throughput screening market, 2014-2021,($ millions)
5.1.3.4. Global diagnostic market, 2014-2021,($ millions)
5.1.3.5. Global drug discovery market, 2014-2021,($ millions)
5.1.3.6. Global other protein microarray market, 2014-2021,($ millions)
5.1.4. Global other array market by application, 2014-2021,($ millions)
5.1.4.1. Global expression profiling market, 2014-2021,($ millions)
5.1.4.2. Global cancer diagnostic market , 2014-2021,($ millions)
5.1.4.3. Global toxico genomics market, 2014-2021,($ millions)
5.1.4.4. Global genomics market, 2014-2021,($ millions)
5.1.4.5. Global drugs discovery market, 2014-2021,($ millions)
5.1.4.6. Global other array market, 2014-2021,($ millions)
5.2. Global biochip market by type, 2014-2021,($ millions)
5.2.1. Global protein microarray market by types, 2014-2021,($ millions)
5.2.1.1. Global expressional protein microarray market , 2014-2021,($ millions)
5.2.1.1.1. Global functional protein microarray market, 2014-2021,($ millions)
5.2.1.1.2. Global reverse phase protein microarray market, 2014-2021,($ millions)
5.2.2. Global other array market by types, 2014-2021,($ millions)
5.2.2.1. Global cell array market , 2014-2021,($ millions)
5.2.2.2. Global tissue array market , 2014-2021,($ millions)
5.2.2.2.1. Global FFPE arrays market , 2014-2021,($ millions)
5.2.2.2.2. Global frozen arrays market , 2014-2021,($ millions)
5.3. Global biochip market by end user, 2014-2021,($ millions)
5.3.1. Research and development tools
5.3.2. Drug discovery and development
5.3.3. Diagnostic centers
5.3.4. Sequencing and other
6. Competitive Landscape
6.1. Market share
6.2. Strategy – An analysis across tiers
7. Geographical analysis
7.1. North America market, 2014-2021,($millions)
7.1.1. United States (U.S.) market, 2014-2021,($millions)
7.1.2. Canada market, 2014-2021,($millions)
7.2. Europe market, 2014-2021,($millions)
7.2.1. United Kingdom (UK) market, 2014-2021,($millions)
7.2.2. France market, 2014-2021,($millions)
7.2.3. Germany market, 2014-2021,($millions)
7.2.4. Spain market, 2014-2021,($millions)
7.2.5. Italy market, 2014-2021,($millions)
7.2.6. RoE market, 2014-2021,($millions)
7.3. Asia Pacific market, 2014-2021,($millions)
7.3.1. India market, 2014-2021,($millions)
7.3.2. China market, 2014-2021,($millions)
7.3.3. Japan market, 2014-2021,($millions)
7.3.4. Korea market, 2014-2021,($millions)
7.3.5. Australia market, 2014-2021,($millions)
7.3.6. RoAPAC market, 2014-2021,($millions)
7.4. Rest of the world market, 2014-2021,($millions)
7.4.1. Latin America market, 2014-2021,($millions)
7.4.2. MENA market, 2014-2021,($millions)
7.4.3. Africa market, 2014-2021,($millions)
8. Company Profiling: - (Over, SCOT analysis, strategic review)
8.1. Agilent technologies
8.2. Affymetrix inc
8.3. Gene system inc
8.4. Agendia BV inc
8.5. Customarray inc
8.6. Digital genomics inc
8.7. Bio chain institute Inc
8.8. Biomerieux SA
8.9. Bio-rad laboratories inc
8.10. Cepheid Inc
8.11. Caliper life sciences inc
8.12. Cybrdi inc
8.13. EMD Millipore
8.14. Elim Biopharmaceuticals
8.15. Falcon Genomics.
8.16. Genalyte
8.17. Oxford gene technology
8.18. Wafergen biosystems inc
8.19. Predictive biosciences
8.20. Fluidigm corp
8.21. Gamida for life group
8.22. Illumina Inc
8.23. Life technologies corp
8.24. Origene technologies Inc
8.25. Perkinelmer inc
8.26. Roche nimblegen inc
8.27. Sequenom
8.28. Sigma aldrich corp
8.29. Imgenex
8.30. ISU ABXIS co. ltd
8.31. Quantalife inc
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Agilent technologies
Affymetrix inc
Gene system inc
Agendia BV inc
Customarray inc
Digital genomics inc
Bio chain institute Inc
Biomerieux SA
Bio-rad laboratories inc
Cepheid Inc
Caliper life sciences inc
Cybrdi inc
EMD Millipore
Elim Biopharmaceuticals
Falcon Genomics
Genalyte
Oxford gene technology
Wafergen biosystems inc
Predictive biosciences
Fluidigm corp
Gamida for life group
Illumina Inc
Life technologies corp
Origene technologies Inc
Perkinelmer inc
Roche nimblegen inc
Sequenom
Sigma aldrich corp
Imgenex
ISU ABXIS co ltd
Quantalife inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll